Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Structure elucidation, biological activity of a novel antimitotic agent: FR-182877

March 7, 2000

Squalamine enters combination trials with cisplatin for advanced cancer

March 7, 2000

Immunomedics updates progress with genetically engineered cancer immunotherapy

March 6, 2000

First report of sequence-specific DNA dialkylation with diamide-CPI conjugate

March 6, 2000

Triapine anticancer therapy completes phase I trial

March 3, 2000

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis

March 3, 2000

Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity

March 3, 2000

CryoLife and Viragen enter cancer therapy collaboration

March 3, 2000

IL-4 gene therapy studied in malignant glioma

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...